The effect of calcium supplements on rectal mucosal proliferation (original) (raw)
- Clinical Oncology/Epidemiology
- Published: 01 January 1995
Clinical Oncology/Epidemiology
British Journal of Cancer volume 71, pages 186–190 (1995) Cite this article
- 149 Accesses
- 19 Citations
- Metrics details
Abstract
Seventy-nine patients with colorectal adenomata were randomised to receive calcium carbonate (3,000 mg) or placebo in a double-blind randomised trial to assess the short- and long-term effects on rectal mucosal proliferation measured by the in vitro metaphase arrest technique crypt cell production rate (CCPR). There was no significant difference in mean CCPR between the groups before treatment or after 3 or 12 months. In those patients randomised to calcium, CCPR fell at both 3 months [9.0 (2.8) cc c-1 h-1, t = 3.15, d.f = 76, P = 0.002] and 12 months [9.2 (3.3) cc c-1 h-1 t = 2.7, d.f. = 74, P = 0.009] compared with pretreatment CCPR [12.2 (5.5) cc c-1 h-1]. We have demonstrated that calcium had no effect on mucosal proliferation compared with placebo. The results on adenoma formation are awaited.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
Author information
Authors and Affiliations
- Department of Surgery, University Hospital, Nottingham, UK
NC Armitage
Authors
- NC Armitage
- PS Rooney
- K-A Gifford
- PA Clarke
- JD Hardcastle
Rights and permissions
About this article
Cite this article
Armitage, N., Rooney, P., Gifford, KA. et al. The effect of calcium supplements on rectal mucosal proliferation.Br J Cancer 71, 186–190 (1995). https://doi.org/10.1038/bjc.1995.38
- Issue date: 01 January 1995
- DOI: https://doi.org/10.1038/bjc.1995.38